RecruitingNCT07130565

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Amyloidosis Cardiac Amyloidosis Amyloid

Summary

To evaluate the potential usefulness of 18F-92/AV45/TPZA/FT8, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Pan-Amyloid-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated cardiac amyloidosis (supporting evidence may include MRI, CT, serum markers and pathology report); (iii) patients who had scheduled Pan-Amyloid PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria1

\- (i) patients with non-CA lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.